Synonyms:
Status: Phase 2
Entry Type: Small molecule
Molecule Category: UKNOWN
UNII: QXA167CM6F

Structure

InChI Key SFYAXIFVXBKRPK-QFIPXVFZSA-N
Smile O=c1ccc2c([C@@H](O)CNCCCCCCOCC(F)(F)c3ccccc3)ccc(O)c2[nH]1
InChI
InChI=1S/C25H30F2N2O4/c26-25(27,18-8-4-3-5-9-18)17-33-15-7-2-1-6-14-28-16-22(31)19-10-12-21(30)24-20(19)11-13-23(32)29-24/h3-5,8-13,22,28,30-31H,1-2,6-7,14-17H2,(H,29,32)/t22-/m0/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C25H30F2N2O4
Molecular Weight 460.52
AlogP 4.23
Hydrogen Bond Acceptor 5.0
Hydrogen Bond Donor 4.0
Number of Rotational Bond 13.0
Polar Surface Area 94.58
Molecular species BASE
Aromatic Rings 3.0
Heavy Atoms 33.0

Pharmacology

Action Mechanism of Action Reference
AGONIST Beta-2 adrenergic receptor agonist PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Asthma 2 D001249 ClinicalTrials
Pulmonary Disease, Chronic Obstructive 2 D029424 ClinicalTrials

Related Entries

Scaffolds

Cross References

Resources Reference
ChEBI 142077
ChEMBL CHEMBL3039530
DrugBank DB12100
EPA CompTox DTXSID60238605
FDA SRS QXA167CM6F
Guide to Pharmacology 9326
SureChEMBL SCHEMBL241483
ZINC ZINC000043150941